Compound information
- Natural Products
- ZC2251628
- Molecular Formula
- C20H24N2O3S
- Molecular Weight
- 372.150763628 g/mol
- Structure
-
- IUPAC Name
- benzyl N-[(1S)-1-(6,7-dihydro-4H-thieno[3,2-c]pyridine-5-carbonyl)-2-methyl-propyl]carbamate
- InChI
- InChI=1S/C20H24N2O3S/c1-14(2)18(21-20(24)25-13-15-6-4-3-5-7-15)19(23)22-10-8-17-16(12-22)9-11-26-17/h3-7,9,11,14,18H,8,10,12-13H2,1-2H3,(H,21,24)/t18-/m0/s1
- InChI Key
- FWGIHUBLJDQOJL-SFHVURJKSA-N
- SMILES
- CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)N1CCc2sccc2C1
- Source
- ZINC000022596868
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 26 | Ring Count | 3 |
Heteroatom Count | 6 | Rotatable Bond Count | 5 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 58.64 Å2 | LogP | 3.523 |
LogS | -4.307 | LogD | 3.901 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.204 | Pgp substrate | 0.72 |
HIA | 0.961 | F20 % | 0.99 |
F30 % | 0.803 | Caco-2 | -4.555 |
MDCK | -4.595 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.003 | PPB | 97.513 |
VD | 1.427 | Fu | 1.745 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.324 | CYP1A2 substrate | 0.797 |
CYP2A6 substrate | 0.55 | CYP2B6 substrate | 0.674 |
CYP2C19 inhibitor | 0.989 | CYP2C19 substrate | 0.935 |
CYP2C8 substrate | 0.891 | CYP2C9 inhibitor | 0.94 |
CYP2C9 substrate | 0.732 | CYP2D6 inhibitor | 0.157 |
CYP2D6 substrate | 0.844 | CYP2E1 substrate | 0.305 |
CYP3A4 inhibitor | 0.628 | CYP3A4 substrate | 0.999 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.494 | CL | 7.633 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.212 | Hepatotoxicity | 0.655 |
Mutagenicity | 0.107 | Rat Oral Acute Toxicity | 0.209 |
FDAMDD | 0.201 | Skin Sensitization | 0.048 |
Carcinogenicity | 0.032 | Eye Corrosion | 0.002 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.607 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.564 | IGC50 | 3.946 |
LC50FM | 4.036 | LC50DM | 5.721 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.255 | NR-AR-LBD | 0.158 |
NR-AhR | 0.055 | NR-Aromatase | 0.036 |
NR-ER | 0.586 | NR-ER-LBD | 0.527 |
NR-PPAR-gamma | 0.191 | SR-ARE | 0.458 |
SR-ATAD5 | 0.526 | SR-HSE | 0.607 |
SR-MMP | 0.071 | SR-p53 | 0.047 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.